Literature DB >> 10085455

Nephrotic mice (ICGN strain): a model of diffuse mesangial sclerosis in infantile nephrotic syndrome.

S Mizuno1, Y Mizuno-Horikawa, B F Yue, M Okamoto, T Kurosawa.   

Abstract

The ICGN mouse strain is a unique model for naturally occurring nephrotic syndrome. In the present study, we examined the onset of the clinical manifestation of nephrotic syndrome and determined the sequence of intraglomerular events associated with progression of nephrotic conditions. Laboratory analysis revealed that homozygous (nep/nep) mice showed urinary albumin excretion during the suckling stage, rapidly leading to hypoalbuminemia accompanied by body growth failure. Renal pathology demonstrated that an initial intraglomerular event in the nephrotic mice was observed 3 weeks after birth in the form of mesangiolytic lesions, characterized by microaneurysm, platelet accumulation and capillary ballooning. In 6-week-old homozygous mice, mesangial sclerosis, characterized by mesangial expansion and glomerular hypertrophy, was observed in a diffuse fashion. Immunohistochemistry revealed that the glomerular cells in the 3-week-old homozygous suckling mice were positive for alpha-smooth muscle actin, suggesting a phenotypic change in the mesangial cells. Mesangial expansion, confirmed by the over-deposition of type I collagen, was evident until 6 weeks after weaning, while it was of interest that fibrogenic cytokines such as platelet-derived growth factor and transforming growth factor-beta were not detected in the sclerotic glomeruli throughout the observations. Furthermore, the nephrotic features were shown to be resistant to steroid therapy with a high dose of prednisolone. Our results suggest that diffuse mesangial sclerosis, a hereditary glomerular disease, may be genetically generated through early myofibroblast formation, which occurs and develops probably independently of up-regulation of these fibrogenic cytokines. In conclusion, the homozygous nephrotic mouse (ICGN strain) is believed to be a good model for investigating not only nephrotic conditions but also cellular and molecular pathogenesis of diffuse mesangial sclerosis in steroid-resistant infantile nephrotic syndrome.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10085455     DOI: 10.1159/000013430

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  7 in total

Review 1.  Animal models of nephrotic syndrome.

Authors:  Ivana Simic; Mansoureh Tabatabaeifar; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2012-12-19       Impact factor: 3.714

2.  The Kidneys of Infant Mice are not Sensitive to the Food Mycotoxin Contaminant Nivalenol.

Authors:  Kaoru Inoue; Miwa Takahashi; Yukio Kodama; Akiyoshi Nishikawa; Yoshiko Sugita-Konishi; Midori Yoshida
Journal:  J Toxicol Pathol       Date:  2014-04-30       Impact factor: 1.628

3.  A Decrease in Glomerular Endothelial Cells and Endothelial-mesenchymal Transition during Glomerulosclerosis in the Tensin2-deficient Mice (ICGN strain).

Authors:  Takashi Kato; Shinya Mizuno; Akihiko Ito
Journal:  Acta Histochem Cytochem       Date:  2014-11-21       Impact factor: 1.938

4.  Nephron, Wilms' tumor-1 (WT1), and synaptopodin expression in developing podocytes of mice.

Authors:  Takashi Kato; Shinya Mizuno
Journal:  Exp Anim       Date:  2017-02-07

Review 5.  Tensin 2-deficient nephropathy: mechanosensitive nephropathy, genetic susceptibility.

Authors:  Hayato Sasaki; Nobuya Sasaki
Journal:  Exp Anim       Date:  2022-04-19

6.  A zebrafish model of congenital nephrotic syndrome of the Finnish type.

Authors:  Mi-Sun Lee; Sulochana Devi; John Cijiang He; Weibin Zhou
Journal:  Front Cell Dev Biol       Date:  2022-09-14

7.  Quantitative trait Loci for resistance to the congenital nephropathy in tensin 2-deficient mice.

Authors:  Hayato Sasaki; Nobuya Sasaki; Tomohiro Nishino; Ken-Ichi Nagasaki; Hiroshi Kitamura; Daisuke Torigoe; Takashi Agui
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.